Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Miguel Pardos
CEO | Chief Executive Officer | - | 01/06/22 |
Santiago Calavia
PRN | Corporate Officer/Principal | - | - |
Julie Moreau
PRN | Corporate Officer/Principal | - | - |
Kamal Abbasi
PRN | Corporate Officer/Principal | - | - |
Jayne Burrell
LAW | General Counsel | 50 | 02/01/15 |
Nairn McMaster
PRN | Corporate Officer/Principal | - | 01/07/11 |
Emilie Croissant
SAM | Sales & Marketing | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Cheng Wei Liu
CHM | Chairman | 50 | - |
Miguel Pardos
CEO | Chief Executive Officer | - | 01/06/22 |
Gen Li
BRD | Director/Board Member | - | 27/04/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 580 157 084 | 315 849 061 ( 54,44 %) | 0 | 54,44 % |
Coordonnées société
Sinclair Pharma Ltd.
Whitfield Court 30-32 Whitfield Street
W1T 2RQ, London
+44 20 7467 6920
http://www.sinclairpharma.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+19,98% | 43,48 Md | |
+20,67% | 22,65 Md | |
+14,56% | 14,73 Md | |
+14,32% | 13,79 Md | |
+44,72% | 12,04 Md | |
-8,37% | 7,08 Md | |
-0,05% | 6,79 Md | |
-8,87% | 5,73 Md | |
+11,90% | 5,47 Md |